BrightSpring Health Services, Inc. BTSG
62.09 USD -1.93 (-3.01%)
As ofNov 20, 2026, 2:34 PM EST
62.06 Day range 64.16
32.72 52-week range 73.75
- YTD
- +65.79%
- 1 year
- +89.53%
News
zacks.com Does BrightSpring Health Services, Inc. (BTSG) Have the Potential to Rally 29.69% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in BrightSpring Health Services, Inc. (BTSG). While the effectiveness of this highly sought-after metric…
fxempire.com BrightSpring (BTSG) Price Forecast: Inverse Head-and-Shoulders Signals Upside Potential BrightSpring shares pull back after an inverse head-and-shoulders breakout, with key Fibonacci support levels likely to determine whether the advance toward $85.42 resumes.benzinga.com BMO Capital Maintains Outperform on BrightSpring Health, Raises Price Target to $84 BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $80 to $84.
zacks.com Buy 5 Stocks at 52-Week High With More Upside for the Short Term ACEL, ASUR, BTSG, CLMB and CHE are five stocks trading near 52-week highs that offer double-digit short-term upside potential.
zacks.com Best "Strong Buy" Stocks Trading Near Their Highs to Buy as the Nasdaq Falls Find surging Zacks Rank #1 (Strong Buy) stocks that are thriving and trading near their 52-week highs even as the broader market tanks and AI stocks tumble.
seekingalpha.com Healthcare Stocks Overtake Tech: 5 Strong Buys Combining Growth And Value Healthcare's emerging leadership combines defensive demand with long-term growth; the sector has gained over 22% year-to-date and more than 11% over one month. Five Quant Strong Buy stocks in the…benzinga.com Guggenheim Maintains Buy on BrightSpring Health, Raises Price Target to $84 Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.
benzinga.com UBS Maintains Buy on BrightSpring Health, Raises Price Target to $92 UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $85 to $92.
benzinga.com Leerink Partners Maintains Outperform on BrightSpring Health, Raises Price Target to $92 Leerink Partners analyst Whit Mayo maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $72 to $92.
benzinga.com TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $84 TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.
benzinga.com Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $82 Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $78 to $82.
benzinga.com BrightSpring Health Q3 2026 Earnings Call Transcript BrightSpring Health (NASDAQ:BTSG) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com BrightSpring Health Q3 Adj. EPS $0.54 Beats $0.47 Estimate, Sales $4.213B Beat $3.875B Estimate BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.47 by 14.89 percent. This is a 80 percent increase over earnings of…
benzinga.com BrightSpring Health Raises FY2026 Sales Guidance from $15.100B-$15.425B to $15.900B-$16.125B vs $15.346B Est BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $15.100 billion-$15.425 billion to $15.900 billion-$16.125 billion vs $15.346 billion estimate.
